​

Acelyrin Ownership | Who Owns Acelyrin?

OverviewForecastFinancialsChartTranscripts

Acelyrin Ownership Summary

Acelyrin is owned by 21.55% institutional investors, 7.14% insiders, and 71.31% retail investors. Millennium management is the largest institutional shareholder, holding 0.15% of SLRN shares.

SLRN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAcelyrin21.55%7.14%71.31%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management149.30K0.15%$368.77K
China universal asset management21.27K0.02%$66.80K
Woodline partners lp---
Geode capital management---
Voya investment management---
Proshare advisors---
Cerity partners---
Yakira capital management---
Prudential financial---
Price t rowe associates inc /md/---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
China universal asset management21.27K0.01%$66.80K
Millennium management149.30K0.00%$368.77K
Woodline partners lp---
Geode capital management---
Voya investment management---
Proshare advisors---
Cerity partners---
Yakira capital management---
Prudential financial---
Price t rowe associates inc /md/---

Top Buyers

HolderShares% AssetsChange
China universal asset management21.27K0.01%2.08K
Skopos labs---62.00
Allworth financial lp---65.00
Pnc financial services group---71.00
Rothschild investment---85.00

Top Sellers

HolderShares% AssetsChange
Tang capital management---9.82M
Ayurmaya capital management company, lp---9.33M
Blackrock funding, inc. /de---5.81M
T. rowe price investment management---4.65M
Millennium management149.30K0.00%-4.57M

Sold Out

HolderChange
Skopos labs-62.00
Allworth financial lp-65.00
Pnc financial services group-71.00
Rothschild investment-85.00
Eversource wealth advisors-96.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20258-93.50%21,397,921-75.25%210.29%2-96.67%2-94.87%
Dec 31, 202424-80.49%12,406,379-85.49%120.17%12-81.54%7-79.41%
Sep 30, 20241237.89%85,479,826-1.74%851.11%65-7.14%3436.00%
Jun 30, 2024114-7.32%86,992,477-4.26%871.02%70-2.78%25-13.79%
Mar 31, 20241236.03%90,862,8497.15%920.64%729.09%297.41%

Recent Insider Transactions

DateNameRoleActivityValue
Mar 17, 2025Kim Mina Chief Executive OfficerSell$49.35K
Mar 17, 2025Murugan Amar Chief Legal OfficerSell$10.74K
Mar 17, 2025Mpofu Shephard Chief Medical OfficerSell$8.81K
Jul 17, 2024Becker Daniel J.-Sell$6.86
Jan 02, 2024Lin Shao-Lee Chief Executive OfficerSell$79.19K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1-3
2024 Q4--
2024 Q3-1
2024 Q1-1

SLRN Ownership FAQ

Who Owns Acelyrin?

Acelyrin shareholders are primarily institutional investors at 21.55%, followed by 7.14% insiders and 71.31% retail investors. The average institutional ownership in Acelyrin's industry, Biotech Stocks , is 307.10%, which Acelyrin falls below.

Who owns the most shares of Acelyrin?

Acelyrin’s largest shareholders are Millennium management (149.3K shares, 0.15%), China universal asset management (21.27K shares, 0.02%), and Woodline partners lp (0 shares, 0%). Together, they hold 0.17% of Acelyrin’s total shares outstanding.

Does Blackrock own Acelyrin?

BlackRock is not among the top 10 institutional shareholders of Acelyrin.

Who is Acelyrin’s biggest shareholder by percentage of total assets invested?

China universal asset management is Acelyrin’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 21.27K Acelyrin shares, valued at 66.8K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools